| Antivirals Like Tamiflu
Boost H1N1 Virus Infectivity
A study conducted by the National Institute for Viral Disease
Control and Chinese Center for Disease Control and Prevention
has found that the antiviral Tamiflu (oseltamivir) boosts H1N1
viral infection.
The study presented in Biochemical
and Biophysical Research Communications showed that tests
from two wild 2009 H1N1 virus strains, A/California/07/09 and
A/Sichuan/1/09, as well as a seasonal flu virus, A/Baoan/51/2008,
confirmed these findings.
Antivirals have been found to consistently cause
pneumonia and respiratory failure.
The WHO reports that populations are
increasingly becoming resistant to antivirals such as Tamiflu
for the current H1N1 pandemic virus.
Numerous reports and studies have already linked Tamiflu to dozens
of deaths worldwide in apparently very health children. The British
Medical Journal reported that children
with seasonal flu should not be given Tamiflu because harmful
side effects may outweigh relatively meager benefits. Yet antivirals
are one of the primary tools used by Longini and Halloran to prevent
a pandemic. On the contrary, antivirals would only accelerate
it.
Tamiflu and other antivirals lower body temperatures. They make
people (who can still transmit the virus) asymptomatic for longer
periods and can therefore be expected to facilitate and contribute
to the spread of a pandemic. If populations begin taking Tamiflu
as a preventive measure, it could potentially cause the reverse
of the intended effect, causing an explosion of viral transmission.
*
A full list of h1n1 vaccine ingredients, alerts and warnings.
Reference Sources: sciencedirect.com
December 7, 2009
 ...............................................................................................................
|
